Stock News & Analysis

Keurig Dr Pepper delivered strong third-quarter results and raised its revenue guidance. But investors still seem unconvinced that the company's $18 billion coffee gambit is a good move.

Some of the largest drugmakers in the world are trading at attractive valuations. Are they worth buying?

Daqo investors are getting good news on multiple fronts.

Did President Trump just issue another big, bullish catalyst for cryptocurrencies?

Sify published its fiscal Q2 results over the weekend, and the stock is pulling back sharply in Monday's trading.

Wall Street analysts are deeply split on which way Plug Power is heading.

The trade war between the U.S. and China cooled off over the weekend.

Tesla has big ambitions, but is facing near-term headwinds.

Key big tech partners provide IonQ with a clear roadmap for scaling its operations.

You could boost your monthly income by hundreds of dollars with spousal benefits.

IonQ recently made a major breakthrough in quantum networking.

Not all high-dividend ETFs are cut from the same cloth. Sometimes, that's a good thing.

This pharma giant is entering the rapidly expanding market for weight loss drugs.

The pharma giant is slated to report its latest quarterly numbers next week.